- Home
- Publications
- Publication Search
- Publication Details
Title
Cabergoline in acromegaly
Authors
Keywords
Acromegaly, Cabergoline, Somatostatin analogues, Pegvisomant, Pituitary adenoma
Journal
Pituitary
Volume 20, Issue 1, Pages 121-128
Publisher
Springer Nature
Online
2016-12-26
DOI
10.1007/s11102-016-0782-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study
- (2016) Manuel Puig-Domingo et al. Endocrinologia y Nutricion
- The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical data
- (2015) Carmela Caputo et al. Lancet Diabetes & Endocrinology
- THERAPY OF ENDOCRINE DISEASE: The challenges in managing giant prolactinomas
- (2014) Dominique Maiter et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
- (2014) Thomas J. Moore et al. JAMA Internal Medicine
- Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study
- (2013) Irina Bancos et al. CLINICAL ENDOCRINOLOGY
- Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas
- (2013) Renata S Auriemma et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study
- (2013) Maya Barake et al. Pituitary
- No Evidence of a Detrimental Effect of Cabergoline Therapy on Cardiac Valves in Patients with Acromegaly
- (2012) Luigi Maione et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
- (2012) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The changing face of acromegaly—advances in diagnosis and treatment
- (2012) Antônio Ribeiro-Oliveira Jr et al. Nature Reviews Endocrinology
- Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literature
- (2012) Grace Lam et al. Neurosurgical Focus
- Pegvisomant and cabergoline combination therapy in acromegaly
- (2012) I. Bernabeu et al. Pituitary
- Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study
- (2011) Victoria Delgado et al. CLINICAL ENDOCRINOLOGY
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Medical therapy in acromegaly
- (2011) Mark Sherlock et al. Nature Reviews Endocrinology
- Cardiac valve disease and low-dose dopamine agonist therapy: an artefact of reporting bias?
- (2010) Haotian Gu et al. CLINICAL ENDOCRINOLOGY
- Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline
- (2010) M Lafeber et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short- and Long-Term Efficacy of Combined Cabergoline and Octreotide Treatment in Controlling IGF-I Levels in Acromegaly
- (2010) Priscilla Mattar et al. NEUROENDOCRINOLOGY
- Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR
- (2010) Lucio Vilar et al. Pituitary
- Transnasal trans-sphenoidal endoscopic repair of CSF leak secondary to invasive pituitary tumours using a nasoseptal flap
- (2010) B. Thakur et al. Pituitary
- Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma
- (2009) INTERNAL MEDICINE JOURNAL
- Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin Analogues
- (2009) M. Sherlock et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide
- (2009) Raquel S. Jallad et al. NEUROENDOCRINOLOGY
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia.
- (2008) Magnus Löndahl et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Clinical use of cabergoline as primary and adjunctive treatment for acromegaly
- (2008) V J Moyes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- No Greater Incidence or Worsening of Cardiac Valve Regurgitation with Somatostatin Analog Treatment of Acromegaly
- (2008) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mortality in Acromegaly: A Metaanalysis
- (2007) O. M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started